FDA
-
-
-
-
-
-
-
Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Pivotal Trial
-
-
-
-
-
-
-
Hancock Jaffe Announces Significant Improvements in all Study Endpoints For Final VenoValve First-in-Human Data
-
-
-
-
-
-
-
Hancock Jaffe Submits VenoValve Pre-IDE Filing to FDA
-
-
-
-
-
-
-
Hancock Jaffe Regains Compliance with Nasdaq Stockholder's Equity Rule
-
-
-
-
-
-
-
Hancock Jaffe Announces Plans for CoreoGraft First-in-Human Study
-
-
-
-
-
-
-
Hancock Jaffe Reports Positive Results for 6 Month CoreoGraft Animal Feasibility Study
-
-
-
-
-
-
-
Hancock Jaffe to Host Virtual Roadshow Webinar on Thursday, October 3, 2019 at 4:30 p.m. Eastern Time
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

